First Time Loading...

Catalent Inc
NYSE:CTLT

Watchlist Manager
Catalent Inc Logo
Catalent Inc
NYSE:CTLT
Watchlist
Price: 45.59 USD -0.44%
Updated: Sep 26, 2023

Operating Margin
Catalent Inc

-3.2%
Current
13%
Average
8.2%
Industry
Negative for the last year
-3.2%
Positive average
13%
Worse than average
Worse than industry value

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-3.2%
=
Operating Profit
-137m
/
Revenue
4.3B

Operating Margin Across Competitors

Operating Margin Comparison
Catalent Inc Competitors

Country Company Market Cap Operating
Margin
US
Catalent Inc
NYSE:CTLT
8.2B USD
-3%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 551T JPY
-16%
US
Eli Lilly and Co
NYSE:LLY
523B USD
29%
US
Johnson & Johnson
NYSE:JNJ
414B USD
29%
DK
Novo Nordisk A/S
CSE:NOVO B
2.2T DKK
43%
US
Merck & Co Inc
NYSE:MRK
269B USD
34%
CH
Roche Holding AG
SIX:ROG
198B CHF
32%
UK
AstraZeneca PLC
LSE:AZN
174B GBP
19%
CH
Novartis AG
SIX:NOVN
193B CHF
25%
US
Pfizer Inc
NYSE:PFE
185B USD
38%
FR
Sanofi SA
PAR:SAN
129B EUR
22%
Catalent Inc
NYSE:CTLT
Country US
Market Cap 8.2B USD
Operating Margin
-3%
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Country JP
Market Cap 776 551T JPY
Operating Margin
-16%
Eli Lilly and Co
NYSE:LLY
Country US
Market Cap 523B USD
Operating Margin
29%
Johnson & Johnson
NYSE:JNJ
Country US
Market Cap 414B USD
Operating Margin
29%
N
Novo Nordisk A/S
CSE:NOVO B
Country DK
Market Cap 2.2T DKK
Operating Margin
43%
Merck & Co Inc
NYSE:MRK
Country US
Market Cap 269B USD
Operating Margin
34%
R
Roche Holding AG
SIX:ROG
Country CH
Market Cap 198B CHF
Operating Margin
32%
AstraZeneca PLC
LSE:AZN
Country UK
Market Cap 174B GBP
Operating Margin
19%
N
Novartis AG
SIX:NOVN
Country CH
Market Cap 193B CHF
Operating Margin
25%
Pfizer Inc
NYSE:PFE
Country US
Market Cap 185B USD
Operating Margin
38%
Sanofi SA
PAR:SAN
Country FR
Market Cap 129B EUR
Operating Margin
22%

Operating Margin Distribution

Operating Margin Distribution
Pharmaceuticals Industry

Profitability Report

View the profitability report to see the full profitability analysis for Catalent Inc.

Full Profitability Report

See Also

Summary
CTLT intrinsic value, competitors valuation, and company profile.
DCF Valuation
CTLT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CTLT stock valuation using valuation multiples.
Wall Street Estimates
CTLT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CTLT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Other Stocks
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-3.2%
=
Operating Profit
-137m
/
Revenue
4.3B
What is the Operating Margin of Catalent Inc?

Based on Catalent Inc's most recent financial statements, the company has Operating Margin of -3.2%.

ALPHA SPREAD
Join more than 75,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Pricing Terms of Service Privacy Policy Affiliate Program

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2023 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.